Immediate Impact
1 from Science/Nature 49 standout
Citing Papers
Resistance mechanisms to immune checkpoint inhibitors: updated insights
2025 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Maria Rusan being referenced
RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1 -Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Maria Rusan | 303 | 255 | 264 | 29 | 760 | |
| C Ekedahl | 82 | 122 | 178 | 45 | 728 | |
| Rose Mary S. Stocks | 280 | 238 | 328 | 42 | 893 | |
| Robert Middleton | 78 | 55 | 345 | 37 | 970 | |
| Arundhati Rao | 151 | 66 | 296 | 49 | 937 | |
| Ajit Auluck | 75 | 63 | 186 | 35 | 838 | |
| K. Lynn Cates | 89 | 130 | 109 | 38 | 975 | |
| Carmen Martín Carreras‐Presas | 108 | 108 | 59 | 22 | 730 | |
| Vassilios Papadakis | 67 | 184 | 93 | 57 | 864 | |
| Joshua K. Tay | 90 | 35 | 82 | 35 | 705 | |
| W. M. Tilakaratne | 60 | 37 | 121 | 25 | 704 |
All Works
Login with ORCID to disown or claim papers
Loading papers...